Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France
Matthieu Million, Jean‐Christophe Lagier, Philippe Gautret, et al.
Travel Medicine and Infectious Disease (2020) Vol. 35, pp. 101738-101738
Open Access | Times Cited: 479

Showing 1-25 of 479 citing articles:

Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
Peter Horby, Marion Mafham, Louise Linsell, et al.
New England Journal of Medicine (2020) Vol. 383, Iss. 21, pp. 2030-2040
Open Access | Times Cited: 1175
Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
Samia Arshad, Paul E. Kilgore, Zohra Chaudhry, et al.
International Journal of Infectious Diseases (2020) Vol. 97, pp. 396-403
Open Access | Times Cited: 556
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
Caleb P Skipper, Katelyn A Pastick, Nicole Engen, et al.
Annals of Internal Medicine (2020) Vol. 173, Iss. 8, pp. 623-631
Open Access | Times Cited: 533
Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial
Remo H.M. Furtado, Otávio Berwanger, Henrique Fonseca, et al.
The Lancet (2020) Vol. 396, Iss. 10256, pp. 959-967
Open Access | Times Cited: 360
From Diagnosis to Treatment: Recent Advances in Patient-Friendly Biosensors and Implantable Devices
Pei Li, Gunhee Lee, Su Yeong Kim, et al.
ACS Nano (2021) Vol. 15, Iss. 2, pp. 1960-2004
Closed Access | Times Cited: 272
Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Christopher Butler, Jienchi Dorward, Ly‐Mee Yu, et al.
The Lancet (2021) Vol. 397, Iss. 10279, pp. 1063-1074
Open Access | Times Cited: 272
Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis
Jean‐Christophe Lagier, Matthieu Million, Philippe Gautret, et al.
Travel Medicine and Infectious Disease (2020) Vol. 36, pp. 101791-101791
Open Access | Times Cited: 254
Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial
Peter Horby, Marion Mafham, Louise Linsell, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 239
Azithromycin in the treatment of COVID-19: a review
Daniel Echeverría-Esnal, Clara Martín‐Ontiyuelo, María Eugenia Navarrete-Rouco, et al.
Expert Review of Anti-infective Therapy (2020) Vol. 19, Iss. 2, pp. 147-163
Open Access | Times Cited: 233
Self-medication practices during the COVID-19 pandemic among the adult population in Peru: A cross-sectional survey
Jean Franco Quispe-Cañari, Evelyn Fidel-Rosales, Diego Manrique, et al.
Saudi Pharmaceutical Journal (2020) Vol. 29, Iss. 1, pp. 1-11
Open Access | Times Cited: 231
Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation?
Chanu Rhee, Sanjat Kanjilal, Meghan A. Baker, et al.
Clinical Infectious Diseases (2020) Vol. 72, Iss. 8, pp. 1467-1474
Open Access | Times Cited: 220
Virological and clinical cure in COVID‐19 patients treated with hydroxychloroquine: A systematic review and meta‐analysis
Phulen Sarma, Hardeep Kaur, Harish Kumar, et al.
Journal of Medical Virology (2020) Vol. 92, Iss. 7, pp. 776-785
Open Access | Times Cited: 200
Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19
Bhagteshwar Singh, Hannah Ryan, Tamara Kredo, et al.
Cochrane library (2021) Vol. 2021, Iss. 2
Open Access | Times Cited: 190
Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies
Awadhesh Kumar Singh, Akriti Singh, Ritu Singh, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2020) Vol. 14, Iss. 4, pp. 641-648
Open Access | Times Cited: 184
Could there be a link between oral hygiene and the severity of SARS-CoV-2 infections?
Victoria Sampson, Nawar Kamona, Ariane Sampson
BDJ (2020) Vol. 228, Iss. 12, pp. 971-975
Open Access | Times Cited: 184
An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies
Kuldeep Dhama, Shailesh Kumar Patel, Mamta Pathak, et al.
Travel Medicine and Infectious Disease (2020) Vol. 37, pp. 101755-101755
Open Access | Times Cited: 180
Assessment of self-medication practices in the context of the COVID-19 outbreak in Togo
Arnold Junior Sadio, Fifonsi Adjidossi Gbeasor‐Komlanvi, Yao Rodion Konu, et al.
BMC Public Health (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 177
Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection
Peter A. McCullough, Ronan J. Kelly, Gaetano Ruocco, et al.
The American Journal of Medicine (2020) Vol. 134, Iss. 1, pp. 16-22
Open Access | Times Cited: 162
Pharmaceutical compounds used in the COVID-19 pandemic: A review of their presence in water and treatment techniques for their elimination
Carlos Augusto Morales-Paredes, Joan Manuel Rodríguez-Díaz, Nuria Boluda Botella
The Science of The Total Environment (2021) Vol. 814, pp. 152691-152691
Open Access | Times Cited: 151
Natural history of COVID-19 and therapeutic options
Philippe Gautret, Matthieu Million, Pierre‐André Jarrot, et al.
Expert Review of Clinical Immunology (2020) Vol. 16, Iss. 12, pp. 1159-1184
Closed Access | Times Cited: 143
COVID-19 and its cardiovascular effects: a systematic review of prevalence studies
Pierpaolo Pellicori, Gemina Doolub, Chih Wong, et al.
Cochrane library (2021) Vol. 2022, Iss. 4
Open Access | Times Cited: 129
Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers
C. Glenn Begley, Mark Ashton, Jonathan B. Baell, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 612
Closed Access | Times Cited: 112
Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: A respiratory virus snapshot
Sophie Amrane, Hervé Tissot‐Dupont, Barbara Doudier, et al.
Travel Medicine and Infectious Disease (2020) Vol. 36, pp. 101632-101632
Open Access | Times Cited: 129
Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients
Srinivasa Reddy Bonam, Srini V. Kaveri, Anavaj Sakuntabhai, et al.
Cell Reports Medicine (2020) Vol. 1, Iss. 2, pp. 100016-100016
Open Access | Times Cited: 128
“Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis.”
Awadhesh Kumar Singh, Akriti Singh, Ritu Singh, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2020) Vol. 14, Iss. 4, pp. 589-596
Open Access | Times Cited: 128
Page 1 - Next Page

Scroll to top